Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

5.49USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$5.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,494
52-wk High
$10.41
52-wk Low
$4.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 3.42 -0.421
Jun '18 2.39 -0.989
Mar '18 2.37 -0.654
FY 2017 Dec '17 13.00 -2.122
Sep '17 3.30 -1.513
Jun '17 3.76 -0.541
Mar '17 3.92 -0.663
FY 2016 Dec '16 20.38 8.418
Sep '16 0.00 -1.981
Jun '16 0.00 -1.470
Mar '16 0.00 -1.292
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 2.99 3.60 2.39 0.00
Quarter Ending Mar-19 2 2.48 2.60 2.37 --
Year Ending Dec-18 2 11.18 11.80 10.56 0.00
Year Ending Dec-19 2 8.18 10.56 5.80 --
Earnings (per share)
Quarter Ending Dec-18 2 -0.49 -0.42 -0.56 -0.56
Quarter Ending Mar-19 2 -0.47 -0.35 -0.58 --
Year Ending Dec-18 2 -2.56 -2.48 -2.63 -25.52
Year Ending Dec-19 2 -2.08 -1.69 -2.46 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta 1.47 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) 0.71 15.60 5.12
Price to Tangible Book (MRQ) 0.71 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 31.80 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.23 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago 4.79 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate 25.26 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 25.42 5.42 3.11
LT Debt to Equity (MRQ) 0.00 33.58 11.47
Total Debt to Equity (MRQ) 0.00 35.41 15.63
Interest Coverage (TTM) -- -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.71 11.83
Operating Margin (TTM) -- -728.63 4.90
Operating Margin - 5 Yr. Avg. -- -526.19 7.44
Pre-Tax Margin (TTM) -- -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,363 898,926,015
Net Income/Employee (TTM) -1,102,105 2,194,067 106,550,787
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.87 -1.11 11.50
Return on Assets - 5 Yr. Avg. -52.08 2.88 12.67
Return on Investment (TTM) -41.68 0.28 15.02
Return on Investment - 5 Yr. Avg. -55.12 1.84 16.45
Return on Equity (TTM) -41.68 0.94 16.60
Return on Equity - 5 Yr. Avg. -55.12 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 0.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Arcturus Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 14.69%
# of Holders: 25
Total Shares Held: 1,572,102
3 Mo. Net Change: 261,637
# New Positions: 7
# Closed Positions: 4
# Increased Positions: 12
# Reduced Positions: 8
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.